tradingkey.logo

Privia Health Group Inc

PRVA

19.320USD

+0.460+2.44%
Horarios del mercado ETCotizaciones retrasadas 15 min
2.35BCap. mercado
150.14P/E TTM

Privia Health Group Inc

19.320

+0.460+2.44%
Más Datos de Privia Health Group Inc Compañía
Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improve patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The platform supports multiple provider types, enables scalable operations, and delivers patient centric in-person and virtual access to care, quality metrics, and lower cost of care. It provides management services to each Medical Group though a local management services organization.
Información de la empresa
Símbolo de cotizaciónPRVA
Nombre de la empresaPrivia Health Group Inc
Fecha de salida a bolsaApr 29, 2021
Director ejecutivoMr. Parth Mehrotra
Número de empleados1140
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 29
Dirección950 N. Glebe Rd., Suite 700
CiudadARLINGTON
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal22203
Teléfono15713668850
Sitio Webhttps://www.priviahealth.com/
Símbolo de cotizaciónPRVA
Fecha de salida a bolsaApr 29, 2021
Director ejecutivoMr. Parth Mehrotra
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
301.84K
-1.09%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
267.95K
-14.94%
Mr. Thomas A. (Tom) Mccarthy
Mr. Thomas A. (Tom) Mccarthy
Independent Director
Independent Director
49.88K
+20.24%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+36.84%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+43.90%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
7.67K
--
Mr. Edward C. Fargis
Mr. Edward C. Fargis
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
--
--
Ms. Nancy G. Cocozza
Ms. Nancy G. Cocozza
Independent Director
Independent Director
--
--
Mr. David King
Mr. David King
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Shawn Morris, CPA
Mr. Shawn Morris, CPA
Director
Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
301.84K
-1.09%
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
267.95K
-14.94%
Mr. Thomas A. (Tom) Mccarthy
Mr. Thomas A. (Tom) Mccarthy
Independent Director
Independent Director
49.88K
+20.24%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+36.84%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+43.90%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
7.67K
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
FFS-patient care
311.76M
64.94%
Capitated revenue
70.69M
14.72%
Shared savings
47.91M
9.98%
FFS-administrative services
32.26M
6.72%
Care management fees
15.20M
3.17%
Other revenue
2.28M
0.47%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
FFS-patient care
311.76M
64.94%
Capitated revenue
70.69M
14.72%
Shared savings
47.91M
9.98%
FFS-administrative services
32.26M
6.72%
Care management fees
15.20M
3.17%
Other revenue
2.28M
0.47%
Estadísticas de accionistas
Actualizado: mar., 20 de may
Actualizado: mar., 20 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.81%
BlackRock Institutional Trust Company, N.A.
12.65%
Durable Capital Partners LP
9.42%
The Vanguard Group, Inc.
9.23%
Rubicon Founders, LLC
4.74%
Other
51.15%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
12.81%
BlackRock Institutional Trust Company, N.A.
12.65%
Durable Capital Partners LP
9.42%
The Vanguard Group, Inc.
9.23%
Rubicon Founders, LLC
4.74%
Other
51.15%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
62.85%
Investment Advisor/Hedge Fund
19.34%
Hedge Fund
12.33%
Individual Investor
6.71%
Research Firm
3.30%
Pension Fund
1.43%
Bank and Trust
0.38%
Sovereign Wealth Fund
0.06%
Venture Capital
0.04%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
514
129.82M
106.48%
-7.97M
2025Q1
530
136.71M
112.18%
-7.58M
2024Q4
523
135.99M
112.85%
-22.61M
2024Q3
533
137.04M
114.53%
-19.89M
2024Q2
535
137.24M
115.06%
-22.76M
2024Q1
525
138.01M
116.30%
-17.09M
2023Q4
500
129.42M
109.89%
-22.91M
2023Q3
486
123.27M
105.26%
-25.19M
2023Q2
471
121.24M
104.92%
-8.36M
2023Q1
415
110.23M
95.73%
-8.00M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
15.62M
12.81%
-159.09K
-1.01%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
15.42M
12.65%
-335.16K
-2.13%
Mar 31, 2025
Durable Capital Partners LP
11.49M
9.42%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
11.25M
9.23%
-149.15K
-1.31%
Mar 31, 2025
Rubicon Founders, LLC
5.77M
4.74%
--
--
Mar 31, 2025
Boehler (Adam)
5.77M
4.74%
+455.34K
+8.56%
Mar 01, 2025
Riverbridge Partners, LLC
5.52M
4.53%
-306.79K
-5.27%
Mar 31, 2025
State Street Global Advisors (US)
4.11M
3.37%
-133.52K
-3.15%
Mar 31, 2025
Principal Global Investors (Equity)
2.96M
2.42%
-122.33K
-3.97%
Mar 31, 2025
Geode Capital Management, L.L.C.
2.50M
2.05%
+90.27K
+3.75%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
Global X HealthTech ETF
2.47%
SPDR S&P Health Care Services ETF
1.91%
Invesco S&P SmallCap Health Care ETF
1.72%
BNY Mellon Innovators ETF
0.95%
First Trust Nasdaq Lux Digi Health Solutions ETF
0.93%
Harbor Human Capital Factor US Small Cap ETF
0.58%
First Trust Small Cap Growth AlphaDEX Fund
0.57%
Langar Global HealthTech ETF
0.5%
WisdomTree US SmallCap Quality Growth Fund
0.38%
iShares U.S. Healthcare Providers ETF
0.38%
Ver más
Global X HealthTech ETF
Proporción2.47%
SPDR S&P Health Care Services ETF
Proporción1.91%
Invesco S&P SmallCap Health Care ETF
Proporción1.72%
BNY Mellon Innovators ETF
Proporción0.95%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción0.93%
Harbor Human Capital Factor US Small Cap ETF
Proporción0.58%
First Trust Small Cap Growth AlphaDEX Fund
Proporción0.57%
Langar Global HealthTech ETF
Proporción0.5%
WisdomTree US SmallCap Quality Growth Fund
Proporción0.38%
iShares U.S. Healthcare Providers ETF
Proporción0.38%
Dividendos
Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI